EGETIS THERAPEUTICS (Germany) Analysis
| P0F Stock | EUR 0.38 0.01 2.56% |
EGETIS THERAPEUTICS AB is overvalued with Real Value of 0.35 and Hype Value of 0.38. The main objective of EGETIS THERAPEUTICS stock analysis is to determine its intrinsic value, which is an estimate of what EGETIS THERAPEUTICS AB is worth, separate from its market price. There are two main types of EGETIS THERAPEUTICS's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect EGETIS THERAPEUTICS's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of EGETIS THERAPEUTICS's stock to identify patterns and trends that may indicate its future price movements.
The EGETIS THERAPEUTICS stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and EGETIS THERAPEUTICS's ongoing operational relationships across important fundamental and technical indicators.
EGETIS |
EGETIS Stock Analysis Notes
About 61.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Egetis Therapeutics AB , a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rareniche diseases with unmet medical needs in the orphan drug segment. Egetis Therapeutics AB was founded in 2006 and is based in Stockholm, Sweden. EGETIS THERAPEUTICS operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11 people. To find out more about EGETIS THERAPEUTICS AB contact Nicklas Westerholm at 46 86 79 72 10 or learn more at http://www.egetis.com.EGETIS THERAPEUTICS Investment Alerts
| EGETIS THERAPEUTICS generated a negative expected return over the last 90 days | |
| EGETIS THERAPEUTICS has high historical volatility and very poor performance | |
| EGETIS THERAPEUTICS has some characteristics of a very speculative penny stock | |
| EGETIS THERAPEUTICS has high likelihood to experience some financial distress in the next 2 years | |
| About 61.0% of the company outstanding shares are owned by corporate insiders |
EGETIS Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 110.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate EGETIS THERAPEUTICS's market, we take the total number of its shares issued and multiply it by EGETIS THERAPEUTICS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 22nd of September, EGETIS THERAPEUTICS shows the standard deviation of 5.97, and Mean Deviation of 3.6. Concerning fundamental indicators, the technical analysis model provides you with a way to check possible technical drivers of EGETIS THERAPEUTICS, as well as the relationship between them. Please confirm EGETIS THERAPEUTICS standard deviation, information ratio, maximum drawdown, as well as the relationship between the variance and treynor ratio to decide if EGETIS THERAPEUTICS is priced some-what accurately, providing market reflects its regular price of 0.38 per share.EGETIS THERAPEUTICS Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. EGETIS THERAPEUTICS middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for EGETIS THERAPEUTICS. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
EGETIS THERAPEUTICS Outstanding Bonds
EGETIS THERAPEUTICS issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. EGETIS THERAPEUTICS uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most EGETIS bonds can be classified according to their maturity, which is the date when EGETIS THERAPEUTICS AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
EGETIS THERAPEUTICS Predictive Daily Indicators
EGETIS THERAPEUTICS intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EGETIS THERAPEUTICS stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 0.38 | |||
| Day Typical Price | 0.38 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
EGETIS THERAPEUTICS Forecast Models
EGETIS THERAPEUTICS's time-series forecasting models are one of many EGETIS THERAPEUTICS's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary EGETIS THERAPEUTICS's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About EGETIS Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how EGETIS THERAPEUTICS prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling EGETIS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as EGETIS THERAPEUTICS. By using and applying EGETIS Stock analysis, traders can create a robust methodology for identifying EGETIS entry and exit points for their positions.
Egetis Therapeutics AB , a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rareniche diseases with unmet medical needs in the orphan drug segment. Egetis Therapeutics AB was founded in 2006 and is based in Stockholm, Sweden. EGETIS THERAPEUTICS operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding EGETIS THERAPEUTICS to your portfolios without increasing risk or reducing expected return.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Complementary Tools for EGETIS Stock analysis
When running EGETIS THERAPEUTICS's price analysis, check to measure EGETIS THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EGETIS THERAPEUTICS is operating at the current time. Most of EGETIS THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of EGETIS THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EGETIS THERAPEUTICS's price. Additionally, you may evaluate how the addition of EGETIS THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |